A study conducted by a collaborative team led by researchers from the University of Southern California (USC) may lead to better insight into the clinical outcome for some patients with a particularly aggressive type of brain cancer. The research may also provide a framework for development of targeted drug treatments. The research by The Cancer […]

Read More

LOS ANGELES (Reuters) – Testing lung cancer patients for tumor markers would enable doctors to choose which drug the patient is most likely to respond to, improving the chances for successful treatment, according to results from a recent trial. The mid-stage study, conducted at the University of Texas M.D. Anderson Cancer Center in Houston and […]

Read More